Tabulong, Janeth A.

HRN: 27-49-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/01/2025
09/05/2025
IV
2.25g
Q8
Pleural Effusion
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines